Decoding Clue: Analyzing the business model of a pioneering enterprise in the femtech field

Decoding Clue: Analyzing the business model of a pioneering enterprise in the femtech field

Edited and introduced by Pham Phuong Linh

The clearest testament to the femtech boom is the significant increase in mobile health applications that track women's health indicators. This is reflected in the figure of 9265.9 million USD - the estimated size of this application market projected to reach 9265.9 million USD by 2030. This market is divided into many different areas, including: fitness and nutrition, menstrual health, pregnancy monitoring and postpartum care, menopause, disease management and other categories. In particular, when mentioning tracking applications, we cannot help but mention Clue - one of the businesses that develops pioneering women's health monitoring and forecasting technology. Clue's CEO, Ms. Ida Tin, was also the first person to introduce the concept of "Femtech" in 2016.

Remarkable fundraising journey

Image source: Clue

Seed round: Founded in 2012, Clue secured €43.8 million ahead of the seed round, bringing its cumulative funding to €50.8 million. The round was led by Balderton Capital and Union Square Ventures, demonstrating investor support and confidence in Clue's mission to put knowledge and data in the hands of women so they can take charge of their health and reproduction.

Series A: In 2015, Clue received $7 million in Series A funding from Union Square Ventures (USV), a venture capital firm known for its investments in technology startups . This round of funding has enabled Clue to expand its team, enhance the app's features, and accelerate its user acquisition efforts.

Series B: Building on its early success, Clue raised $20 million in Series B funding in 2019. The round was led by Nokia Growth Partners (NGP) and joined by other investors such as Union Square Ventures.

Series C: In 2021, Clue announced a $40 million Series C funding round, marking a major milestone in the company's growth journey. The round was led by EQT Ventures, with participation from investors including Union Square Ventures and NGP. With this funding, Clue aims to expand its global reach, strengthen its research initiatives, and continue to innovate its app to better serve user needs.

Throughout its funding journey, Clue has attracted attention from investors for its mission to empower individuals to understand and manage their reproductive health. The company's commitment to privacy, data security, and inclusivity has also resonated with stakeholders in the rapidly growing Femtech scene.

Clue's business model is also notable, revolving around providing reproductive health services focusing on menstrual cycle tracking and pregnancy monitoring. With $47.8 million raised from 22 investors, Ms. Ida Tin has propelled the company to become a leading innovator in the femtech sector, while remaining true to Clue's core values of empowerment, privacy, accessibility, and trust. During its development, Clue has made scientific research on the female body more accessible and is trusted by more than 4.5 million users worldwide. With its intuitive tracking app, Clue not only revolutionized the way women track their reproductive health but also pioneered a unique business model that combines: Freemium services, Data monetization, and Strategic partnerships

Freemium model: Attract and retain users

Freemium is a combination of the words "free" and "premium". This is a term for a type of business model that involves providing customers with both free and paid services. Companies adopting this model will provide simple and basic services for free for everyone to try; while also offering more premium services or additional features at a premium price.

Image source: techeu

The freemium business model is considered the foundation for Clue's success from the early stages. This strategy ensures a steady stream of income for the company by offering users the option to access advanced features through a paid subscription. First, the app provides users with a set of highly accurate tracking and forecasting features for menstrual cycles, fertility, and fertility knowledge, all for free. This strategic approach reduces barriers to entry in accessing health services and products, attracting a wide user base. Within a year of launch, for example, Clue amassed a large and loyal customer base with 11 million users worldwide. By providing essential functions at no cost, Clue positions itself as a trusted companion in women's healthcare, offering the right resource for individuals who want to learn and manage their menstrual cycle.

Furthermore, Clue's freemium model is designed to drive user engagement and retention. The app leverages personalized notifications, educational content, and community features to help users actively participate in their reproductive health journey. This sustained engagement not only enhances user satisfaction but also increases the likelihood of users upgrading to premium features, like cycle analysis and personalized health insights, or participating in optional paid services. Clue anonymizes and aggregates user data (if applicable) for potential monetization, all while keeping user privacy a top priority. This comprehensive approach contributes to Clue's stable revenue stream.

Data Monetization: Create impact with valuable user insights

In addition to its freemium services, Clue also leverages the wealth of anonymous user data collected through its app to generate additional revenue streams. By carefully anonymizing (e.g., removing identifiers) and processing this data, Clue transforms raw data into valuable insights on menstrual health trends, fertility patterns, and more. These insights are valuable not only to users through personalized features, but also to researchers, healthcare providers, and other stakeholders in the women's health ecosystem. For instance, anonymized data on menstrual cycles could be sold to pharmaceutical companies to aid in developing new medications. This approach allows Clue to generate revenue while upholding its commitment to user privacy.

Image source: Glossy

Clue's data monetization strategy involves partnering with research institutions, pharmaceutical companies, and other organizations to license access to its anonymized data sets. For example, in 2021, Clue partnered with L’Oréal, a global beauty company, to delve deeper into the relationship between skin health and the menstrual cycle. By providing access to a vast trove of user-generated data, the company enables stakeholders to conduct groundbreaking research, develop innovative products, and improve healthcare outcomes in women's health. This symbiotic relationship between Clue and its data consumers not only generates revenue but also advances scientific understanding and drives positive social impact.

Strategic partnerships: Expanding reach and impact

To expand its reach and impact in the femtech market, Clue has leveraged partnerships and collaborations in a smart and effective way. These partnerships include a variety of stakeholders, such as healthcare providers, research organizations, advocacy groups, and industry players. Each party contributes unique resources and expertise to enhance Clue's services.

A notable example of Clue's strategic partnerships is its collaboration with healthcare providers and organizations. By integrating with electronic health record systems, telemedicine platforms, and other healthcare infrastructure, Clue enhances its value proposition for both users and healthcare professionals by improving healthcare delivery. This integration enables seamless data sharing between users and their healthcare providers, facilitating more informed discussions, personalized care, and better health outcomes.

Furthermore, Clue actively engages in collaboration with researchers and advocacy groups to advance scientific understanding and promote women's health advocacy initiatives. By supporting research, participating in awareness campaigns, and elevating marginalized voices in discussions about women's health, the company demonstrates its commitment to driving positive change beyond its digital platforms. Strategic partners accompanying Clue in this activity include Bayer, Fitbit, Apple, Google, and L'Oréal.

Overall, it is clear that Clue's business represents innovation, impact, and sustainability in the femtech sector. Through freemium services, data monetization strategies, and strategic partnerships, Clue is not only revolutionizing the way women track and manage their reproductive health, but is also driving advances in scientific research, healthcare service delivery, and policy advocacy initiatives. As women's health awareness grows, it is essential to recognize and promote the potential of impactful solutions like Clue.

Reference source:

Decoding Clue: Analyzing the business model of a pioneering enterprise in the femtech field

Useful for business

KisStartup JSC